BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28497177)

  • 41. The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review.
    Meregaglia M; Nicod E; Drummond M
    Eur J Health Econ; 2023 Sep; 24(7):1151-1216. PubMed ID: 36335234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using Published Health Utilities in Cost-Utility Analyses: Discrepancies and Issues in Cardiovascular Disease.
    Zhou T; Chen Z; Li H; Xie F
    Med Decis Making; 2021 Aug; 41(6):685-692. PubMed ID: 33813938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic review of health state utility values for economic evaluation of colorectal cancer.
    Jeong K; Cairns J
    Health Econ Rev; 2016 Dec; 6(1):36. PubMed ID: 27541298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Health Utilities for Multiple Sclerosis.
    Hawton A; Green C
    Value Health; 2016 Jun; 19(4):460-8. PubMed ID: 27325338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The State of Cost-Utility Analyses in Asia: A Systematic Review.
    Thorat T; Lin PJ; Neumann PJ
    Value Health Reg Issues; 2015 May; 6():7-13. PubMed ID: 29698196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A systematic review of health state utility values and psychometric performance of generic preference-based instruments for children and adolescents with mental health problems.
    Thai TTH; Engel L; Perez JK; Tan EJ; Eades S; Sanci L; Mihalopoulos C
    Qual Life Res; 2023 Nov; 32(11):3005-3026. PubMed ID: 37237136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can we better prioritize resources for cost-utility research?
    Neumann PJ; Rosen AB; Greenberg D; Olchanski NV; Pande R; Chapman RH; Stone PW; Ondategui-Parra S; Nadai J; Siegel JE; Weinstein MC
    Med Decis Making; 2005; 25(4):429-36. PubMed ID: 16061895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of loneliness and social isolation on health state utility values: a systematic literature review.
    Majmudar IK; Mihalopoulos C; Brijnath B; Lim MH; Hall NY; Engel L
    Qual Life Res; 2022 Jul; 31(7):1977-1997. PubMed ID: 35072904
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Systematic Literature Review of Health Utility Values in Breast Cancer.
    Kaur MN; Yan J; Klassen AF; David JP; Pieris D; Sharma M; Bordeleau L; Xie F
    Med Decis Making; 2022 Jul; 42(5):704-719. PubMed ID: 35042379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating health state utility values for joint health conditions: a conceptual review and critique of the current evidence.
    Ara R; Wailoo AJ
    Med Decis Making; 2013 Feb; 33(2):139-53. PubMed ID: 22927696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An updated systematic review of Health State Utility Values for osteoporosis related conditions.
    Peasgood T; Herrmann K; Kanis JA; Brazier JE
    Osteoporos Int; 2009 Jun; 20(6):853-68. PubMed ID: 19271098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimating health-state utility values for patients with recurrent ovarian cancer using Functional Assessment of Cancer Therapy - General mapping algorithms.
    Hettle R; Borrill J; Suri G; Wulff J
    Clinicoecon Outcomes Res; 2015; 7():615-27. PubMed ID: 26648747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis.
    Hawton A; Shearer J; Goodwin E; Green C
    Appl Health Econ Health Policy; 2013 Aug; 11(4):331-41. PubMed ID: 23637055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measuring costs in cost-utility analyses. Variations in the literature.
    Stone PW; Chapman RH; Sandberg EA; Liljas B; Neumann PJ
    Int J Technol Assess Health Care; 2000; 16(1):111-24. PubMed ID: 10815358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health State Utility Values for Age-Related Macular Degeneration: Review and Advice.
    Butt T; Tufail A; Rubin G
    Appl Health Econ Health Policy; 2017 Feb; 15(1):23-32. PubMed ID: 27637920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Identification, Review and Synthesis of Health State Utility Values from the Literature.
    Ara R; Brazier J; Peasgood T; Paisley S
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):43-55. PubMed ID: 29052156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists.
    Zoratti MJ; Pickard AS; Stalmeier PFM; Ollendorf D; Lloyd A; Chan KKW; Husereau D; Brazier JE; Krahn M; Levine M; Thabane L; Xie F;
    Eur J Health Econ; 2021 Jul; 22(5):723-733. PubMed ID: 33839968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PERFORMANCE OF OVID MEDLINE SEARCH FILTERS TO IDENTIFY HEALTH STATE UTILITY STUDIES.
    Arber M; Garcia S; Veale T; Edwards M; Shaw A; Glanville JM
    Int J Technol Assess Health Care; 2017 Jan; 33(4):472-480. PubMed ID: 29065942
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.